| Dhingra Ankur |
SVP, Chief Financial Officer |
ILLUMINA, INC. (ILMN)
|
2025-05-12 |
$81.21 |
0.0% |
6,100
|
$495,381 |
| Dhingra Ankur |
Chief Financial Officer |
Summit Therapeutics Inc. (SMMT)
|
2024-03-26 |
$3.75 |
233.3% |
100,000
|
$375,000 |
| Dhingra Ankur |
Chief Financial Officer |
Summit Therapeutics Inc. (SMMT)
|
2023-12-13 |
$2.17 |
476.2% |
20,400
|
$44,254 |
| Dhingra Ankur |
Chief Financial Officer |
Summit Therapeutics Inc. (SMMT)
|
2023-03-07 |
$1.05 |
1090.5% |
196,362
|
$206,180 |
| Dhingra Ankur |
Chief Financial Officer |
Summit Therapeutics Inc. (SMMT)
|
2022-08-16 |
$0.97 |
1188.7% |
36,215
|
$35,129 |
| Dhingra Ankur |
Chief Financial Officer |
CareDx, Inc. (CDNA)
|
2021-11-24 |
$42.34 |
-35.9% |
5,000
|
$211,694 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
268.8% |
$3,675,606 |
$1,367,637 |